Meanwhile, earnings before interest, tax, depreciation, and amortisation (EBITDA) surged multifold to ₹128 crore, reflecting ...

Wockhardt now intends to file a new drug application (NDA) with the USFDA and seek marketing authorisation application with ...

Zaynich could play a key role in treating patients suffering from complicated urinary tract infections caused by ...

What drove Wockhardt share price today? Wockhardt share price jumped in a weak market after it announced through an exchange filing that a life-saving antibiotic developed by it achieves over 97 ...

Wockhardt Limited incorporated in July 1999 is a global pharmaceutical and biotechnology organization providing affordable high-quality medicines for a healthier world. The Company is India's leading ...

Wockhardt share price jumped as much as 4 per cent in early trade on Monday, January 13, defying weak market sentiment. Wockhardt shares opened at ₹1,375.05 against their previous close of ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Company has B S R & Co. LLP as its auditors. As on 31-12-2024, the company has a total of 16.25 Crore shares outstanding.Wockhardt Share Price Today is Rs. 1652.60. On previous day, the Wockhardt ...

Pursuant to Regulation 39(3) of the Listing Regulations, we wish to inform you that our RTA has intimated regarding loss of share certificate by the Shareholder. Drugmaker Wockhardt on Wednesday ...